IL SB3550

Establishes a pilot program beginning January 1, 2027 to provide long-acting injectable medications for substance use disorders to incarcerated individuals with drug problems in Illinois Department of Corrections facilities.

Requires the pilot program to operate in at least one correctional facility, with the Director of Corrections authorized to expand to additional facilities as deemed appropriate.

Mandates a minimum of 4,000 administrations of long-acting injectable medications be included in the pilot program.

Requires the Department of Corrections to report to the General Assembly on the program's effectiveness by January 1, 2028.

Amends the Unified Code of Corrections (730 ILCS 5/3-2-2) to add this new substance use disorder treatment requirement.